Effect of Machine Learning–Triggered Nudges on Serious Illness Conversations, End-of-Life Outcomes Among Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6303?guestAccessKey=992d1f64-f12e-43c6-bbdb-f2cb3ca98faf&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011223

Incidence, Factors Associated With Suicide Among Patients Undergoing Surgery for Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 12, 2023 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6549?guestAccessKey=25d9622a-1ab9-4d82-9db2-5fbaa6a6996b&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011223   About The Study: The incidence of suicide…

JAMAONCO_OF:01122023

Postoperative Restrictive Opioid Protocols, Changes in Opioid Prescribing, Chronic Use

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 5, 2023 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6278?guestAccessKey=a621554c-d2a3-4f1a-88cf-1e17713d89f6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010523   About The Study: Implementation of a restrictive opioid prescription…

JAMAONCO_OF:01052023

Association of COVID-19 Vaccination With Breakthrough Infections, Complications in Patients With Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 29, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.6815?guestAccessKey=24522c3a-b9d4-4e26-bf45-d58917926399&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122922   About The Study: In this large population-based study, patients…

JAMAONCO_OF:12292022

SARS-CoV-2 Spike Protein Antibody Response, Infection Severity in Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5974?guestAccessKey=8104ff79-e2ca-4536-8313-f6cf2bc9d3c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122222

JAMAONCO_OF:12222022

JAMAONCO_OF:12152022

JAMAONCO_OF:12082022

Medical Marijuana Legalization and Opioid- and Pain-Related Outcomes Among Patients Receiving Cancer Treatment

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 1, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5623?guestAccessKey=492f0176-1a29-4c42-8737-9cad14a67fd4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=120122   About The Study: The findings of this study suggest…

JAMAONCO_OF:12012022

Disparities in Inclusion of Racial, Ethnic Minority Groups in Prostate Cancer Clinical Trials

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 23, 2022 Media advisory: The full is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5511?guestAccessKey=f799505c-99e1-4b63-a9b1-95df0244791e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=112322   About The Study: The results of this meta-analysis of 286…

JAMAONCO_OF:11232022

Rates of Routine Cancer Screening, Diagnosis Before vs After Pandemic

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 17, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5481?guestAccessKey=a155d93d-a9e8-4b05-b0be-66f75cffca20&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111722   About The Study: In this cross-sectional study of data…

Association of Residential Racial, Economic Segregation With Cancer Mortality

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, NOVEMBER 17, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5382?guestAccessKey=64d5e78b-c977-480e-bec8-a7a695fb5338&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=111722   About The Study: The findings of this…

JAMAONC_OF:11172022

JAMAONCO_11112022

JAMAONCO_OF:11102022

JAMAONCO_OF:11032022

Interplay of Immunosuppression, Immunotherapy Among Patients With Cancer and COVID-19

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5357?guestAccessKey=6675d993-046d-41dd-a65b-ff8ef1ddc33e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

Fracture Risk Among Older Cancer Survivors Compared With Older Adults Without a History of Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.5153?guestAccessKey=4b9ee6a0-8c06-4724-a94a-62b411d1afd9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=110322

Serious Adverse Event Reporting in Cancer Clinical Trials During the Pandemic

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4919?guestAccessKey=440e57f5-0e8a-4e92-b1fe-77c4de070477&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102722

JAMAONCO_OF:10272022

Association of Prostate-Specific Antigen Screening Rates With Subsequent Metastatic Prostate Cancer Incidence at Veterans Health Administration Facilities

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4319?guestAccessKey=64418a55-4d5c-4a34-aae3-4b74ebe425c2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=102422

JAMAONCO_ADHOC:10232022

JAMAONCO_ADHOC:10242022

JAMAONCO_OF:10202022

JAMAONCO_OF:10132022

Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, OCTOBER 13, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4649?guestAccessKey=246957dc-cae4-4aa6-939d-7509f42444e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=101322   About The Study: Invasive breast cancer rates…

JAMAONCO_OF:10062022

JAMAONCO_OF:09292022

Identification of Deaths Caused by Cancer, COVID-19 in US From March to December 2020

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 29, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4315?guestAccessKey=109b8e0c-720b-4003-ae1b-b603a1faa0a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092922   About The Study: This analysis shows that in the…

JAMAONCO_OF:09222022

Inhibition of Omicron BA.1, BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.4226?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=092222

JAMAONCO_OF:09152022

JAMAONCO_ADHOC:09122022

JAMAONCO_OF:09082022

JAMAONCO_OF:09012022

Visual Abstract: Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3829?guestAccessKey=efae0fdc-ee29-440a-bcb1-3851ebb46e11&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122   Visual Abstract Authors: Thierry…

Visual Abstract: Efficacy, Safety of Telaglenastat Plus Cabozantinib in Patients With Advanced Renal Cell Carcinoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 1, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3511?guestAccessKey=c6ad7a6b-caf2-411c-a706-d6e65b18d0c6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090122   Visual Abstract…

JAMAONCO_OF:08252022

Reporting of Race and Hispanic Ethnicity in Breast Cancer Studies From the National Cancer Database

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3527?guestAccessKey=df819b8f-2bea-41e3-a44d-a56c120be434&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522

Relapse Rates and Disease-Specific Mortality Following Procedures for Fertility Preservation at Time of Breast Cancer Diagnosis

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3677?guestAccessKey=14d8ef3b-d59d-4322-aee4-d8ef1be7480d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082522

JAMAONCO_08182022

Visual Abstract: Etoposide, Cisplatin vs Irinotecan, Cisplatin for Neuroendocrine Carcinoma of Digestive System

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 18, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3395?guestAccessKey=686b68ae-7de7-4777-9e3c-13a3fe86deb8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081822   Visual Abstract Authors: Chigusa…

JAMAONC_OF:08112022

Antibody Response of 3-Dose COVID-19 Vaccination Schedule in Immunocompromised Patients With Hematologic Cancers

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 11, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.3227?guestAccessKey=0b9a95d7-73d1-49c0-a5a8-c690dae47ecc&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081122   About The Study: In this study that included 584…

JAMAONCO_OF:08042022

Association Between PSA Screening, Prostate Cancer Mortality Among Non-Hispanic Black, Non-Hispanic White Veterans

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 4, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2970?guestAccessKey=06430554-cf5a-42e4-b950-adbebba956fa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080422   About The Study: In this study of 45,800 U.S….

JAMAONCO_OF:07282022

Daily Insulin Dose, Cancer Risk Among Patients With Type 1 Diabetes

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 28, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2960?guestAccessKey=b87b1296-2d13-4778-adc8-6ef8cfe9425f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822   About The Study: This study investigated the associations of…

Lung Cancer Risk Among Smokers for Whom Annual Screening Is Not Recommended

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2952?guestAccessKey=3997d5dd-38bd-4549-a346-9f6ad30ddf3c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072822

JAMAONCO_OF:07212022

Incidence of Anaplastic Large-Cell Lymphoma of the Breast in US

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2624?guestAccessKey=4c6c9ff4-348c-4a3d-be6d-a933bd35a8b4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072122

JAMAONCO_OF:07142022

Visual Abstract: Preoperative mFOLFIRINOX With vs Without Hypofractionated Radiotheraphy for Borderline Resectable Adenocarcinoma of the Pancreas

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 14, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2319?guestAccessKey=19be8691-33c6-45fa-a57d-449b14057ad6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071422   Visual Abstract…

JAMAONCO_OF:07072022

Plant-Based, Ketogenic Diets As Diverging Paths to Address Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1769?guestAccessKey=6fcb6393-e7d5-4721-8be2-c93131f59772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722

Worldwide Association of COVID-19 Pandemic Measures With Cancer Screening

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 7, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2617?guestAccessKey=bad2cff1-e56b-4697-840b-d5046c557c22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070722   About The Study: The results of this systematic review…

Visual Abstract: Effect of Community Health Worker Intervention on Acute Care Use in Advanced Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1997?guestAccessKey=4689aac9-0b9e-49bc-ba6e-af3010634318&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022   Visual Abstract…

Visual Abstract: Effect of Apatinib Plus Pegylated Liposomal Doxorubicin vs Pegylated Liposomal Doxorubicin Alone on Platinum-Resistant Recurrent Ovarian Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2253?guestAccessKey=d809d096-4cd9-4e27-9c36-c802e22956bd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022   Visual Abstract Authors: Ning…

JAMAONCO_OF:06302022

Opioid Management in Individuals With Advanced Cancer-Related Pain, Opioid Misuse or Use Disorder

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 30, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2191?guestAccessKey=5a825031-95be-41f4-8be4-9f3be6dd5772&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=063022   About The Study: The findings of this…

JAMAONCO_ADHOC:06282022

JAMAONCO_OF:06232022

Visual Abstract: Ipilimumab vs FOLFOX in ERBB2-Positive Esophagogastric Adenocarcinoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.2228?guestAccessKey=88a81f35-fbee-41a3-a7fc-574429ec2cf4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322   Visual Abstract…

Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race, Ethnicity

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1990?guestAccessKey=3d042976-b580-42b8-a1f0-341ff4cef611&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322   About The Study: This study of 45,000…

Environmental Outcomes Associated With Transition From In-Person to Virtual Conference During COVID-19

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 23, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1925?guestAccessKey=9cff5e2e-0789-4421-be52-8d3dd58455a9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062322   About The Study: Researchers estimated the change in travel-related…

JAMAONCO_OF:06162022

Visual Abstract: Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1641?guestAccessKey=27101ae2-0299-4636-ae46-9e6c928e13e1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   Visual Abstract…

Visual Abstract: Efficacy of Pegasparaginase-Based Chemotherapy Regimen vs L-asparaginase–Based Regimen for Extranodal Natural Killer/T-Cell Lymphoma

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1968?guestAccessKey=e677efdb-e05c-46f6-9c45-8250fba74408&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   Visual Abstract…

Assessing Risk of Maternal Death in Pregnancies Complicated by Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 16, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1795?guestAccessKey=53666fe6-8c61-4ef6-8aa1-925d724bbda0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061622   About The Study: Researchers examined nationwide trends and characteristics…

JAMAONCO_OF:06092022

Risk Factors, Racial, Ethnic Disparities in Patients With Breast Cancer–Related Lymphedema

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1628?guestAccessKey=f59cfb53-9e1c-4d40-8d10-0d77617ef26c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922

Assessment of Compliance With Centers for Medicare & Medicaid Services Price Transparency Final Rule

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1783?guestAccessKey=ed7608dc-a4c6-4f38-b178-fbec153a9283&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060922

JAMAONCO_OF:06022022

JAMAONCO_OF:05262022

Visual Abstract: Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 26, 2022 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1479?guestAccessKey=b74760fc-69e3-4e2a-83f2-8d34a94ca3b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=052622   Visual Abstract…

JAMAONCO_OF:05242022

JAMAONCO_OF:05192022

Change in Cancer Death Rates Among Black Individuals in US

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 19, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1472?guestAccessKey=4f8298ee-74af-4722-870e-e774477e130c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051922   About The Study: Researchers found in this cross-sectional study…

JAMAONCO_OF:05122022

Visual Abstract: Efficacy of Vistusertib With Anastrozole in Recurrent or Metastatic Endometrial Cancer

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1047?guestAccessKey=7ceee02b-5633-46ea-8090-de65d98f5d50&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222   Visual Abstract Authors: Pierre…

Visual Abstract: Treatment With Etirinotecan Pegol for Patients With Metastatic Breast Cancer, Brain Metastases

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 12, 2022 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0514?guestAccessKey=d16b2127-1557-410e-9965-0bfac3675cb4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051222   Visual Abstract Authors: Debu…

JAMAONCO_OF:05052022

Racial, Ethnic Differences in Uterine Cancer Mortality Rates

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0009?guestAccessKey=bc521263-d45e-4eb6-8531-4b0b890fd93e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522   About The Study: This study of 208,000 women showed…

Age at Initiation of Endoscopy, Colorectal Cancer Risk Among Women

JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 5, 2022 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0883?guestAccessKey=8acc231b-cf2a-4115-ae46-e34a7f3d6497&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=050522   About The Study: Compared with no endoscopy,…

JAMAONCO_OF:04282022

JAMAONCO_ADHOC:04222022

Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1467?guestAccessKey=a314a6bb-e264-4ade-86c3-0e104b8f74f9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042222

JAMAONCO_OF:04212022

Durability of Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0752?guestAccessKey=bed65c33-3051-450a-9874-e6858923afd2&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042122

JAMAONCO_OF:04142022

JAMAONCO_ADHOC:04082022

Breakthrough SARS-CoV-2 Infections, Hospitalizations, Mortality in Vaccinated Patients With Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.1096?guestAccessKey=da1de153-897a-41d6-80f6-14ae617e331a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040822

JAMAONCO_OF:04072022

Association of Medicaid Expansion With Mortality Disparity by Race, Ethnicity Among Patients With De Novo Stage IV Breast Cancer

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2022.0159?guestAccessKey=acc01b6e-19ef-42f0-863a-7fcbda037aa6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040722